# Aripiprazole Treatment of the Prodrome

> **NCT00169949** · NA · TERMINATED · sponsor: **Northwell Health** · enrollment: 30 (—)

## Conditions studied

- Prodromal Schizophrenia
- Prodromal Psychosis

## Interventions

- **DRUG:** aripiprazole

## Key facts

- **NCT ID:** NCT00169949
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-01
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 30 (—)
- **Why stopped:** The study was terminated due to low enrollment.
- **Last updated:** 2009-09-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00169949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00169949, "Aripiprazole Treatment of the Prodrome". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00169949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*